+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting

, : Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting. Clinical Advances in Hematology & Oncology 9(11 Suppl 27): 1-14; Quiz 15-6

One of the most dreaded side effects of anticancer treatment, chemotherapy-induced nausea and vomiting (CINV) plays a significant role in cancer patients' morbidity and quality of life. The management of CINV has been refined over the past several decades, and CINV can now be addressed with targeted prophylactic medications aimed at inhibiting the molecular pathways involved in emesis, including serotonin receptor antagonists and neurokinin-1 receptor antagonists. Advances in the understanding of the physiology of CINV, coupled with the introduction of several agents that inhibit activation of these receptors, are reflected in current CINV guidelines. These guidelines, which are largely similar, provide recommendations based on expert review of available clinical trial data. Despite the availability of effective prophylaxis, many patients still suffer from CINV. To minimize these side effects, clinicians should ensure widespread adoption and implementation of at least 1 CINV guideline in their practice. Even when the recommendations are followed, a small group of patients continue to experience CINV, often in the form of nausea, for which few treatments are effective. Current and future studies will begin to delineate the specific pathways for the development of nausea, hopefully leading to the identification of novel agents and regimens with improved efficacy in this setting.


PMID: 22362372

Other references

Liao, C-Hua.; Chen, C-Nien., 2017: Discoid Skin Rash in a Preterm Infant. Journal of Pediatrics 183: 199-199

Johnson, D.S., 1964: Key to Malayan cladocera. Guide Fauna Malaysian Region, 6: 7

Lyoo, Y.S.; Kim JinHyun; Park ChoiKyu, 1999: Identification of porcine circoviruses with genetic variation from lymph nodes collected in pigs with PMWS. Porcine circovirus (PCV) was isolated from pigs [date not given] with post weaning multisystemic wasting syndrome (PMWS) presented at the Konkuk University, Korea Republic. Affected pigs had prominent inguinal lymph node enlargement and hyperaemia...

Hamilton, B.H.; McManus, B., 2012: The effects of insurance mandates on choices and outcomes in infertility treatment markets. For the 10% to 15% of American married couples who experience reproductive problems, in vitro fertilization (IVF) is the leading technologically advanced treatment procedure. However, IVF's expense may prevent many couples from receiving trea...

Amarger, N., 2004: Transgenic bacteria to improve culture conditions?. This article describes the potential use of transgenic bacteria to improve performance in agriculture. The improvement of plant growth and plant protection, using genetically modified microorganisms, is discussed.

Wilker, C., 1998: Are there redeeming qualities in one of nature's toxic orphan receptors?. Toxicologic Pathology 26(5): 672-673

Manitto, P.G.amatica, P.R.nzi, B., 1975: Stereochemistry of the decarboxylation of phenolic cinnamic acids by Saccharomyces cerevisiae. Journal of the Chemical Society: 11 442-443

Knowles, R.; Gupta, B.M.D., 1931: A note on two intestinal protozoa of the Indian mongoose. Indian Journal of Medical Research, 10: 175-176

Tanaka, Y.; Nakashima, F.; Kirii, E.; Goto, T.; Yoshida, Y.; Yasuba, K-Ichiro., 2016: Difference in capsaicinoid biosynthesis gene expression in the pericarp reveals elevation of capsaicinoid contents in chili peppers (Capsicum chinense). This research reveals that the up-regulated expression of multiple capsaicinoid biosynthetic genes in pericarp tissue leads to the elevation of total capsaicinoid content in chili pepper fruit. Capsaicinoids are health-functional compounds that ar...

Kurschus, F.C.; Moos, S., 2017: IL-17 for therapy. The cytokine IL-17 is now a target for an array of therapeutic monoclonal antibodies supposed to treat a variety of inflammatory diseases. The forerunner Secukinumab, an IL-17A neutralizing antibody, is meanwhile approved as first-line treatments...